Pulmatrix Inhales $3M Financing

Xconomy Boston — 

Pulmatrix, a Lexington, MA-based developer of aerosol drugs intended to treat and prevent the spread of respiratory ailments, has raised $3 million in a financing, Mass High Tech reports, citing a regulatory filing. A company spokeswoman says the financing is a bridge round in anticipation of a larger financing, but the firm isn’t commenting on the details of the deal. The six-year-old firm’s previous backers include Waltham, MA, venture firms 5AM Ventures and Polaris Venture Partners. Luke wrote about Pulmatrix in September when it emerged from stealth mode.